Position in IRWD
as of Mar 31, 2026
· filed May 22, 2026
Position Value
$976,485
New position
Shares Held
278,201
first reported quarter
Ownership
0.169%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SEGALL BRYANT & HAMILL, LLC holds $48,800,443 across 13 Drug Manufacturers - Specialty & Generic names. IRWD ranks #9 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
585,769 | $20,712,791 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
56,934 | $7,500,485 | |
| 3 | PAHC |
Phibro Animal Health Corp
|
104,301 | $5,768,888 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
277,802 | $3,453,078 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
34,834 | $2,678,734 | |
| 6 | LQDA |
Liquidia Corp
|
55,938 | $2,111,100 | |
| 7 | SIGA |
Siga Technologies Inc
|
273,522 | $1,463,342 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
23,169 | $1,197,605 |
All Filings in IRWD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $976,485 | 278,201 | Shares | Sole | 2026-05-22 | |
| No filing history on record for this holder in this stock. | ||||||